Literature DB >> 406701

Adverse reactions to isoniazid on ingestion of fish with a high histamine content.

C G Uragoda, S R Kottegoda.   

Abstract

On eating preparations of a particular variety of fish, the skipjack (bonito), patients with tuberculosis on isoniazid repeatedly developed symptoms very similar to those of histamine poisoning. Skipjack was found to contain probably the highest concentration of histamine reported in fish. Isoniazid is a potent inhibitor of histaminase which normally plays an important role in the metabolism of histamine in the body. It is suggested that the symptoms seen in these patients were, in fact, due to histamine. In these circumstances the high histamine content of skipjack and the interference by isoniazid with the metabolism of the amine presumably play complementary roles in the production of histamine poisoning; each of these factors by itself is apparently inadequate to produce such intoxication. An analysis of the symptoms manifested by 21 patients is presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406701     DOI: 10.1016/0041-3879(77)90034-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  5 in total

Review 1.  Histamine (Scombroid) Fish Poisoning: a Comprehensive Review.

Authors:  Charles Feng; Suzanne Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Cerebrovascular accident after a "skipjack" reaction in a patient taking isoniazid.

Authors:  N Senanayake; S Vyravanathan; S Kanagasuriyam
Journal:  Br Med J       Date:  1978-10-21

Review 3.  Prostaglandins and other mediators in food intolerance.

Authors:  M H Lessof; J B Anderson
Journal:  Clin Rev Allergy       Date:  1984-02

4.  Monoamine oxidase inhibitors and histamine metabolism.

Authors:  M S Benedetti; J F Ancher; N Sontag
Journal:  Experientia       Date:  1980-07-15

Review 5.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.